Interv. Cardiol. H. Ramón y Cajal retweeted
"Are current devices for TR repair suitable for CHD patients?" 🫀🫀🫀
Really happy to be able to participate in such a great event at the "Course: All about percutaneous pulmonary valve replacement" by the Pediatric Cardiology and CHD Department, University H. Ramón y Cajal.
CardioValve case no. 8 and no. 7 in the TARGET trial at our center! Another success in our cath lab, great performance of the valve, from massive to trace TR. @ASanchezRecalde @luisa_car @RyCImagenCardio @CardiologiaRyC @PCRonline @shci_sec
The first two MR cases with the DragonFly device! Great teamwork in the cath lab! @ASanchezRecalde @luisa_car @AnaPardo213 @RyCImagenCardio
Interv. Cardiol. H. Ramón y Cajal retweeted
Awesome sessions at ValveDay at the RyC Hospital. Controversies, debates and great discussions. #ValveDay @RyCImagenCardio @CardiologiaRyC @AnaGarciaMart16 @AnaPardo213 @j_alvarezgarcia
Interv. Cardiol. H. Ramón y Cajal retweeted
En el hospital Ramón y Cajal estamos de celebración #TAVI1000 @shci_sec @luisalido @CardiologiaRyC @ASanchezRecalde @ImMSanFer
Interv. Cardiol. H. Ramón y Cajal retweeted
Orgulloso de haber colaborado en "Effect of Duration of Anticoagulation in the Incidence of Stroke in Patients With Left Ventricular Thrombus" en American Journal of Cardiology @ELS_Cardiology
¡Probablemente, en trombo intraventricular tendremos beneficio en prolongar la ACO!
Interv. Cardiol. H. Ramón y Cajal retweeted
Excited to be the first center in the region #Gulf #MiddleEast to use a #TricValve more percutaneous solutions for high risk patients #Bicaval options
@KFAFHCards @fayezbaraah @drptca
productsandfeatures-kunden.d…
@sacisforum @APSIC6 @PCRonline #ACCIC #EAPCI
@Hragy @mmamas1973
Interv. Cardiol. H. Ramón y Cajal retweeted
Study shows the most widely used clinical threshold for CFRthermo (<2.0) has poor sensitivity for identifying coronary microvascular dysfunction.
Read @DrOzanDemir et al. paper to find out more: bit.ly/3sMIO5p
#JACCINT #CFR #Physiology @divaka_perera #CardioTwitter
Great cases at #EuroPCR2022. One day left!
Interv. Cardiol. H. Ramón y Cajal retweeted
An expert review on the technical aspects and outcomes of the variants of the crush technique from its introduction in the early 2000s to present times.#EuroPCR #EAPCI ow.ly/cTo650JbMXE
Interv. Cardiol. H. Ramón y Cajal retweeted
33 Congreso #ACI_SEC
🗓8-10 junio☀️Alicante
Programón de #coronario y #estructural con cardiologos intervencionistas🔝 nacionales e internacionales. Comunicaciones, #LiveCases #CursoFormacion para @JovenesSec y @ResiSec y algunas sorpresas. Apuntate ya en hemodinamica.com
Interv. Cardiol. H. Ramón y Cajal retweeted
Estais ya nerviosos? Ojo a lo q viene!! Lo mejor en #Intervencionismo #Percutaneo #Cardiopatia #Estructural con los mejores expertos. Echa un ojo al programa para #medicos y #enfermeria en este 🧶 👇
Interv. Cardiol. H. Ramón y Cajal retweeted
3D anatomy Model With ECG leads.
IB for Credits.
@grepmeded
Interv. Cardiol. H. Ramón y Cajal retweeted
Thank you to my co-authors @lpbadano @denisamuraru @pe_bartko @drmaisano @PEPEZAMORANO and @DonalErwan: TR Review bit.ly/EHtJCVI_TRReview @ESC_Journals @escardio @ASE360 @echo_stepbystep @EGarciaSayan @robertomlang
Interv. Cardiol. H. Ramón y Cajal retweeted
I think I’ll start listing that I’m 1 of 41 women in interventional cardiology at the level of Associate Professor *in the entire US* on my CV. 🤔
Interv. Cardiol. H. Ramón y Cajal retweeted
This State-of-the-Art reviews the available transcatheter therapies, main criteria for patient and device selection, remaining uncertainties, and future directions. #EAPCI ow.ly/Jfk750GSEmc
Interv. Cardiol. H. Ramón y Cajal retweeted
Desde @HemodinamicaC os deseamos #FelizNavidadParaTodos y un 2022 lleno de alegría y éxitos
#MerryChristmas
#cardioHUN #estructuralHUN – at Pamplona, Spain








































